| Predicate |
Object |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- |
| filingDate |
2000-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2006-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4398b8b3b7a5b1de47bac04f270bc7db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ded7ed6162beca92ed607488b57b4394
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d31d42176c3a152cafc4b3ff2e081b58 |
| publicationDate |
2006-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2268749-C2 |
| titleOfInvention |
Interferon-gamma conjugates |
| abstract |
FIELD: immunology. n SUBSTANCE: invention relates to conjugates having interferon-γ activity. Claimed conjugate contains at least one non-polypeptide group, covalent bonded to IFNG polypeptide, wherein polypeptide contains amino acid sequence differ from starting IFNG polypeptide sequence by at least one added or deleted amino acid residue containing group to add non-polypeptide group. n EFFECT: therapy of diseases of improved effectiveness. n 34 cl, 1 ex |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2661088-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2752620-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9359421-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009124362-A1 |
| priorityDate |
1999-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |